VascVersa completes the setup of Specialised Lab Space
Working alongside QUBIS, VascVersa has now moved into a fully operational lab suite comprised of a spacious, main laboratory and two satellite tissue culture suites.
VascVersa is delighted to work with Alcyomics. The Newcastle based company are highly experienced experts in determining the safety of therapeutic products including advanced cellular therapies.
VascVersa proudly working with Anthony Nolan charity
VascVersa will work with Anthony Nolan Cell & Gene Therapy Services who will support the company by supplying high-quality cord material for VascVersa to facilitate their development of ANGICYTE™ technology.
This face to face event supported by Clarendon Fund Managers provided a fantastic opportunity for the team to showcase ANGICYTE™ technology to a local investor network. VascVersa presented...
VascVersa reach regional finals in Intertrade Ireland Seedcorn Competition 2021. This Seedcorn investor readiness competition was a fantastic opportunity for the company to secure expert feedback...
VascVersa were awarded a place on a prestigious PULSE programme. This was a three-day leadership and entrepreneurship training programme developed by the BIA and the Francis Crick Institute.
NI’s First Cell Therapy Company Secure Six Figure Deal
Award winning Queen’s University spin out VascVersa has completed a six-figure deal in its first investment round led by QUBIS, with support from Co-Fund NI and a group of angel investors from...
VascVersa attend Cell & Gene at the Abbey conference, Galway
VascVersa were excited to attend their first face to face event in 2021 at the beautiful Glenlo Abbey in Galway. This event hosted by HiTech Health was a three-day event featuring international experts...
